SEP-363856: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving SEP-363856

• A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia
  NCT07225712 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
  NCT07759128 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
  NCT06894212 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 73 locations
• A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
  NCT07767903 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations

Common questions

How many recruiting trials involve SEP-363856?

4 recruiting trials across 3 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.